(Toronto, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that the Company’s Chief Executive Officer, Dr. Sven Rohmann, will present a corporate overview at the National Investment Banking Association (“NIBA”) conference on Thursday October 27, 2016 at 10:45am (PT) in the Grand Ballroom, at the Balboa Bay Resort, Newport Beach, CA.
- 0 Comments
- FY2017